Codice QR

CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

IntroductionImmunogenic cell death (ICD) has emerged as a novel option for cancer immunotherapy. The key determinants of ICD encompass antigenicity (the presence of antigens) and adjuvanticity, which involves the release of damage-associated molecular patterns (DAMPs) and various cytokines and chemo...

Descrizione completa

Salvato in:
Autori principali: Faye Naessens, Robin Demuynck, Olga Vershinina, Iuliia Efimova, Mariia Saviuk, Greet De Smet, Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko, Elena Catanzaro, Dmitri V. Krysko
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2024-07-01
Serie:Frontiers in Immunology
Soggetti:
immunogenic apoptosis
fractalkine
cytokines
immunogenic cell death
chemokines
CX3CL1
Accesso online:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1396349/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi